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Abstract. 
 
Oxidative stress and highly speciﬁc decreases
in glutathione (GSH) are associated with nerve cell
death in Parkinson’s disease. Using an experimental
nerve cell model for oxidative stress and an expression
cloning strategy, a gene involved in oxidative stress–
induced programmed cell death was identiﬁed which
both mediates the cell death program and regulates
GSH levels. Two stress-resistant clones were isolated
which contain antisense gene fragments of the transla-
 
tion initiation factor (eIF)2
 
a
 
 and express a low amount
of eIF2
 
a
 
. Sensitivity is restored when the clones are
transfected with full-length eIF2
 
a
 
; transfection of wild-
type cells with the truncated eIF2
 
a
 
 gene confers resis-
tance. The phosphorylation of eIF2
 
a
 
 also results in re-
sistance to oxidative stress. In wild-type cells, oxidative
stress results in rapid GSH depletion, a large increase in
 
peroxide levels, and an inﬂux of Ca
 
2
 
1
 
. In contrast, the
resistant clones maintain high GSH levels and show no
elevation in peroxides or Ca
 
2
 
1
 
 when stressed, and the
GSH synthetic enzyme 
 
g
 
-glutamyl cysteine synthetase
(
 
g
 
GCS) is elevated. The change in 
 
g
 
GCS is regulated
by a translational mechanism. Therefore, eIF2
 
a
 
 is a crit-
ical regulatory factor in the response of nerve cells to
oxidative stress and in the control of the major intracel-
lular antioxidant, GSH, and may play a central role in
the many neurodegenerative diseases associated with
oxidative stress.
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Introduction
 
Although programmed cell death (PCD)
 
1
 
 is a widely used
mechanism for sculpturing the developing nervous system,
its inappropriate activation leads to premature nerve cell
death in neuropathological disorders such as Alzheimer’s
disease (AD) (Yankner, 1996) and Parkinson’s disease
(PD) (Mochizuki et al., 1996). Nerve cell death in both PD
and AD are thought to be linked to oxidative stress, as an-
tioxidant systems are upregulated and there is extensive
evidence for excessive lipid and protein peroxidation (Jen-
ner and Olanow, 1996; Simonian and Coyle, 1996). Associ-
ated with oxidative stress is an early and highly specific de-
crease in the glutathione (GSH) content of the substantia
nigra of PD patients (Perry et al., 1982; Sofic et al., 1992;
Sian et al., 1994) which may precede the death of dopam-
inergic neurons (Dexter et al., 1994). In addition, the inhi-
bition of 
 
g
 
-glutamyl cysteine synthetase (
 
g
 
GCS), the rate-
limiting step in GSH synthesis, results in the selective de-
generation of dopaminergic neurons (Jenner and Olanow,
1996) and also potentiates the toxicity of 6-hydroxy-
 
dopamine, MPTP and MPP
 
1
 
. These data suggest that
GSH and oxidative stress play pivotal roles in the patho-
genesis of AD and PD.
There are several ways in which the concentration of in-
tracellular GSH and the oxidative burden of cells can be
regulated. One of these is through extracellular glutamate.
Although glutamate is generally thought of as both a neu-
rotransmitter and an excitotoxin, extracellular glutamate
can also kill neurons through a non–receptor-mediated
pathway which involves the glutamate-cystine antiporter,
system Xc
 
2
 
 
 
(Bannai and Kitamura, 1980; Murphy et al.,
1989; Sato et al., 1999). Under normal circumstances, the
concentration of extracellular cystine is high relative to in-
tracellular cystine, and cystine is imported via the Xc
 
2 
 
an-
tiporter in exchange for intracellular glutamate. Cystine is
ultimately converted to cysteine and used for protein syn-
thesis and to make the antioxidant GSH. However, when
there is a high concentration of extracellular glutamate,
the exchange of glutamate for cystine is inhibited, and the
cell becomes depleted of cysteine and GSH, resulting in
severe oxidative stress. The cell eventually dies via a series
of events which include the depletion of GSH, a require-
ment for macromolecular synthesis and caspase activity, li-
poxygenase activation, soluble guanylate cyclase activa-
tion, reactive oxygen species (ROS) accumulation, and
finally Ca
 
2
 
1
 
 influx (Murphy et al., 1989; Li et al., 1997a,b;
Tan et al., 1998a,b). PCD caused by oxidative glutamate
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toxicity has characteristics of both apoptosis and necrosis
(Tan et al., 1998a) and has been well studied in primary
neuronal cell cultures (Murphy and Baraban, 1990; Oka et
al., 1993), neuronal cell lines (Miyamoto et al., 1989; Mur-
phy et al., 1989), tissue slices (Vornov and Coyle, 1991),
and in the immortalized mouse hippocampal cell line,
HT22 (Li et al., 1997a,b; Tan et al., 1998a,b). HT22 cells
lack ionotropic glutamate receptors but die within 24 h af-
ter exposure to 1–5 mM glutamate. Although the bio-
chemical events have been well studied, little has been
done to identify the transcriptional/translational changes
that contribute to the glutamate-induced pathway of PCD.
Changes in gene expression clearly play a role in the cell
death cascade since macromolecular synthesis is required
early in the death pathway (Tan et al., 1998a,b). Through
the use of a genetic screen, we identified the 
 
a
 
 subunit of
the translation initiation factor 2 (eIF2
 
a
 
) as a gene whose
expression is involved in oxidative stress–induced cell
death and the regulation of intracellular GSH. eIF2 is a tri-
meric complex involved in the initiation of translation
(Hershey, 1991; Pain, 1996). The complex is made up of
three subunits designated alpha, beta, and gamma, and be-
haves in a manner analogous to the trimeric G-coupled
proteins. The 
 
a
 
 subunit dictates whether protein synthesis
will or will not take place and is often referred to as the
control point for protein synthesis. The eIF2 complex
brings the 40S ribosomal subunit together with the initiat-
ing tRNA
 
met
 
 when eIF2
 
a
 
 is bound to GTP. Upon hydroly-
sis of GTP to GDP, the complex is no longer active and
protein synthesis is not initiated. GDP/GTP exchange
takes place readily with the assistance of a guanine nucle-
otide exchange factor, eIF2B. However, when the 
 
a
 
 sub-
unit of eIF2 is phosphorylated on serine 51, a change in the
conformation enables it to bind and sequester eIF2B, thus
inhibiting GDP/GTP exchange and protein synthesis.
eIF2
 
a
 
 phosphorylation takes place during ischemia (De-
Gracia et al., 1997; Burda et al., 1998), apoptosis (Srivas-
tava et al., 1998; Satoh et al., 1999), viral infection (Sam-
uel, 1993; Wek, 1994), and after Ca
 
2
 
1
 
 influx (Prostko et al.,
1995; Srivastava et al., 1995; Reilly et al., 1998). Therefore,
eIF2
 
a
 
 may have significant roles in the cell death process
after oxidative stress that are separate from its known
function as a regulator of protein synthesis. The experi-
ments described below show that the downregulation or
phosphorylation of eIF2
 
a
 
 protects nerve cells from oxida-
tive stress–induced cell death by inhibiting GSH depletion
and the increase in both ROS and intracellular Ca
 
2
 
1
 
 that
are normally seen in cells exposed to oxidative stress.
These data demonstrate a unique role of eIF2
 
a
 
 in oxida-
tive stress–induced programmed nerve cell death, acting as
a translational switch which dictates whether a cell acti-
vates a survival response or follows a cell death pathway.
eIF2
 
a
 
 may therefore play a central role in neuropatholo-
gies involving nerve cell death which are associated with
oxidative stress.
 
Materials and Methods
 
The following chemicals were purchased from Sigma-Aldrich: puromycin,
TCA, formic acid, GSH, GSH reductase, triethanolamine, sulfosalicylic
acid, NADPH, BSA, glutaraldehyde, and L-glutamic acid (glutamate).
The fluorescent probes 2
 
9
 
,7
 
9
 
-dichlorofluorescein (DCF) diacetate and in-
 
doacetoxymethylester (Indo-1), pluronic F-127, and propidium iodide
were obtained from Molecular Probes. The Coomassie Plus protein assay
reagent and the SuperSignal substrate were both purchased from Pierce
Chemical Co. Immobilon P was purchased from Millipore.
 
Infection with the Retroviral cDNA Library
 
HT22 cells were infected with the retroviral vector pcLXSN containing a
cDNA library derived from the human embryonic lung cell line, MRC-5
(Somia et al., 1999). The library contained 2 
 
3 
 
10
 
6
 
 cDNAs, and the HT22
cells were infected with 
 
z
 
10
 
7
 
 virus particles. The cDNA library contains
both sense and antisense sequences. The retrovirus stably integrates into
the host cell’s genomic DNA and expresses the cDNA inserted between
its long terminal repeats. Clones containing genes that confer glutamate
resistance were identified by selecting cells that survived in 10 mM
glutamate. Genomic DNA from each clone was analyzed by PCR using
primers that straddle the cDNA insert in the retroviral vector. The cDNA
inserts were then subcloned and sequenced. Viral vectors were rescued
from the clones by transfection with an ecotropic helper plasmid. These
viral particles were collected from the media and used to infect the pack-
aging cell line, PA317, which amplified the virus (Miller et al., 1993). The
viral medium from the packaging cells was then used to infect wild-type
HT22 cells in order to confirm that the cDNA was indeed able to make
the HT22 cells resistant to glutamate.
 
Immunoblotting and Northern Blot Procedures
 
Cells were plated at 5 
 
3 
 
10
 
5
 
 cells per 100-mm dish 12–16 h before use and
lysed in sample buffer containing 3% SDS. Lysates were sonicated, pro-
tein concentrations were normalized using the Coomassie Plus protein as-
say reagent from Pierce Chemical Co., and 25 
 
m
 
g protein was loaded per
lane on 12% Tris-glycine SDS-PAGE gels (Novex). Gels were transferred
onto Immobilon P membrane (Millipore) and blocked with 5% milk in
TBS for 1 h at room temperature. An antibody against eIF2
 
a
 
 (Research
Genetics) was shown previously to recognize only phosphorylated eIF2
 
a
 
.
However, in our hands the antibody recognized both phosphorylated and
unphosphorylated protein when the Western blots and lysates were de-
phosphorylated with a mixture of bovine and calf intestine alkaline phos-
phatase. Blots were also probed with antibodies against both phosphory-
lated and total mitogen-activated protein kinase to confirm that proteins
were completely dephosphorylated after treatment with the phosphatases.
Therefore, this anti-eIF2
 
a
 
 antibody was used to determine the levels of
total eIF2
 
a
 
 in the HT22 cells and the resistant clones 8 and 15. The anti-
eIF2
 
a
 
 primary antibody was diluted into 5% BSA in TBS plus Tween 20
(TTBS) at 1:250 and placed on the blot overnight at 4
 
8
 
C. Blots were incu-
bated with the secondary antibody, goat anti–rabbit IgG HRP conjugated
(Bio-Rad Laboratories), for 1 h at room temperature at a dilution of
1:20,000 in 5% milk in TTBS. Blots were exposed to Eastman Kodak Co.
X-OMAT Blue film for chemiluminescence using the SuperSignal sub-
strate from Pierce Chemical Co.
Northern blots of the 
 
g
 
GCS catalytic subunit were done as described in
the original paper in which cDNA clones were isolated (Gipp et al., 1992).
Northern blots were done using a probe consisting of the COOH-terminal
387 amino acids of the protein which detected a single band of
 
 z
 
3.7 kb.
 
Transfection of Full-Length eIF2
 
a
 
 into Clones 8 and 15
 
The full-length cDNA for eIF2
 
a
 
 was obtained from Dr. Miyamoto (Na-
tional Heart, Lung, and Blood Institute, National Institutes of Health, Be-
thesda, MD) and was cloned into the pCLBABEpuro retroviral vector, a
modified version of the pBABEpuro vector (Morgenstern and Land,
1990). This vector was then used for transfection with Lipofectamine
(GIBCO BRL).
 
Production of Retrovirus Expressing the Dominant 
Negative Mutants of eIF2a
 
The cDNA constructs for two mutants of eIF2
 
a
 
 (S51A and S51D) were
obtained from Dr. Kaufman (University of Michigan, Ann Arbor, MI)
and subcloned into pCLBABEpuro. Retroviral vectors were made as de-
scribed (Somia et al., 1999) with either pCLBABE-S51A, pCLBABE-
S51D, or pCLBABEpuro alone. The viral vectors were used to infect
HT22 cells, and infected cells were selected in 4 
 
m
 
g/ml puromycin (Sigma-
Aldrich). The puromycin-resistant cells were tested for glutamate resis-
tance by the 3-[4,5 dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bro-
mide (MTT) cell death assay (Tan et al., 1998b). 
Tan et al. 
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a
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Translation and Degradation Assays
 
For translation assays, cells were labeled in 60-mm dishes with 500,000
cpm of [
 
3
 
H]leucine diluted in DME supplemented with 10% FBS for 30
min. The cells were then washed with ice-cold serum-free DME and lysed
on the dish using 1 ml ice-cold 10% TCA plus 1 mM DTT and 1 mM cold
leucine. Cellular protein was precipitated, dissolved in formic acid, and
the [
 
3
 
H]leucine incorporation was determined by scintillation counting.
The protein concentration was determined using the Coomassie blue plus
protein reagent (Pierce Chemical Co.). The total counts per minute of
[
 
3
 
H]leucine incorporated per milligram of protein for 30 min was calcu-
lated for each sample. Samples were prepared in triplicate. Protein degra-
dation assays were done exactly as described elsewhere (Soucek et al.,
1998). Cells were treated with 100 
 
m
 
g/ml cycloheximide, and protein abun-
dance followed by Western blotting.
 
Growth Assays
 
Five sets of triplicate dishes of cells were plated at 5 
 
3 
 
10
 
4
 
 in 35-mm
dishes. The triplicate sets of each cell type were counted at 12, 24, 48, and
72 h after plating. Cells were dissociated using pancreatase (GIBCO
BRL) for 15 min, resuspended in DME, and placed in Eppendorf tubes.
Cells were counted directly on a Beckman Coulter counter after dilution
in isotonic saline. The data are plotted as cell counts versus time in order
to compare the growth rates for the different clones.
 
GSH Assay
 
Total intracellular reduced GSH and oxidized GSH (GSSG) were mea-
sured as described previously (Tan et al., 1998b). In brief, cells were
plated on 60-mm tissue culture dishes at 2 
 
3
 
 10
 
5
 
 cells per dish 12 h before
adding 2–5 mM glutamate for 10 h and total GSH was assayed. Pure GSH
was used to establish a standard curve.
 
Flow Cytometric Studies
 
Cells were plated on 60-mm dishes at 2 
 
3 
 
10
 
5
 
 cells per dish 12 h before
adding 2–5 mM glutamate for 10 h. Samples were then labeled with the
fluorescent dyes DCF and Indo-1 to determine ROS production and Ca
 
2
 
1
 
influx, respectively. Samples were prepared as described previously (Tan
et al., 1998b).
 
Results
 
eIF2a Is Involved in the Oxidative Glutamate
Toxicity Pathway
 
Although a mechanistic outline of oxidative glutamate
toxicity-mediated PCD has been developed (Li et al.,
1997a,b; Tan et al., 1998a,b), very little is known about the
changes in gene expression that are required for this path-
way. To identify genes that may be involved in cell death
or the protection from cell death, HT22 cells were infected
with a cDNA expression library in a retroviral vector, and
cells resistant to high concentrations of glutamate were se-
lected. The retroviral library contained sense, antisense,
and partial cDNA sequences. Therefore, glutamate resis-
tance could be due to a sense cDNA which when overex-
pressed causes glutamate resistance. Alternatively, a tran-
script from an antisense cDNA could interfere with the
expression of a gene normally required for cell death, or
the product of a partial cDNA fragment may act in a dom-
inant negative manner to block protein function. A fourth
alternative is that during retroviral infection, a cDNA is
inserted into the genome in a way that disrupts or upregu-
lates the normal expression of a gene that is involved in
glutamate-induced cell death. Finally, ploidy sometimes
changes in the cells as they divide, and resistant cells may
arise independently of the retroviral infection due to loss
of chromosomes or chromosome fragments. This consti-
tutes a background level of naturally resistant clones in the
genetic screen. HT22 cells were infected with the retrovi-
ral cDNA library and selected in 10 mM glutamate for
48 h, a condition where all of the cells normally die. The
cDNA inserts in the pool of glutamate-resistant cells were
rescued by remobilizing the vector (Miller et al., 1993),
and a second round of infection and selection identified 12
genes that play a putative role in oxidative glutamate tox-
icity. Identical fragments (213 bp) of the gene encoding
Figure 1. Clones 8 and 15 are resistant to glutamate and express
low levels of eIF2a. Glutamate-resistant cells were cloned after
infecting HT22 cells with a retroviral cDNA expression library.
(A) Cell viability was measured using the MTT assay with wild-
type HT22 cells (white bars), clone 8 (black bars), and clone 15
(hatched bars) after a 24-h exposure to 0, 5, and 10 mM
glutamate. Samples were measured in triplicate on 96-well plates
(n 5 10). (B and C) Glutamate-resistant clones 8 and 15 have
lower levels of eIF2a protein than wild-type HT22 cells which are
largely restored by the reintroduction of wild-type eIF2a. (B)
eIF2a and actin protein levels were detected by Western blotting
of cell lysates (25 mg) from wild-type HT22 cells, glutamate-resis-
tant clones 8 and 15, and clones 8 and 15 transfected with wild-
type eIF2a. Loading controls were actin (blot) and amido black
staining of the blot. Note that the single band which is reduced in
the stained blot in the Cl8 1 eIF2a lane is albumin from the se-
rum in the growth medium which is somewhat variable because
of washing. (C) The density of each protein band was measured
using the program NIH Image, and the average density for each
band was plotted relative to eIF2a in wild-type HT22 cells. Iden-
tical amounts (65%) of actin in each lane served as loading con-
trols. The experiment was repeated at least five times with similar
results. *Significantly different from HT22 wild-type controls
(mean  6  SEM,  P , 0.05). 
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the 
 
a 
 
subunit of eIF2 (eIF2
 
a
 
) were identified in two sepa-
rate clones. This gene was chosen for further study be-
cause of the requirement for protein synthesis in this form
of cell death (Tan et al., 1998a,b). The subclones of HT22,
designated clones 8 and 15, are extremely resistant to 10
mM glutamate and were maintained in the presence of 10
mM glutamate (Fig. 1 A). These clones are also resistant
to other forms of oxidative stress, including hydrogen per-
oxide (H
 
2
 
O
 
2
 
) and tert-butyl hydroperoxide but not to cell
death inducers such as TNF-
 
a
 
, anti-FAS antibody, serum
starvation, and glucose deprivation (data not shown).
 
Clones 8 and 15 Cause Glutamate Resistance by 
Lowering eIF2
 
a
 
 Expression
 
As outlined previously, the introduction of the eIF2
 
a
 
 gene
fragment into clones 8 and 15 with the retroviral cDNA li-
brary could lead to stress resistance by one of several
mechanisms. It is unlikely that the eIF2
 
a
 
 gene fragment is
causing glutamate resistance by disrupting or upregulating
a gene whose expression is involved in cell death because
the same sequence generates glutamate resistance upon
reinfection. This leaves the possibility that the eIF2
 
a
 
cDNA fragment is altering eIF2
 
a
 
 expression. Therefore,
the two resistant clones and wild-type cells were assayed
for eIF2
 
a
 
 expression by Western blotting. Although the
antibody used for these studies can identify the phosphor-
ylated form of eIF2
 
a
 
 (DeGracia et al., 1997), it recognizes
both the dephosphorylated and phosphorylated forms of
eIF2
 
a
 
 in HT22 cells (see Materials and Methods). Using
this antibody, it was found that both clones 8 and 15 ex-
press lower levels of eIF2
 
a
 
 protein (Fig. 1, B and C). Simi-
lar results were obtained with another antibody against
eIF2
 
a
 
 (Ernst et al., 1987).
Since the retroviral expression library contained cDNAs
in both the sense and antisense orientations as well as par-
tial fragments of cDNAs, it is likely that an antisense frag-
ment was expressed to downregulate eIF2
 
a
 
 expression.
The gene fragments that were rescued from clones 8 and
15 are identical and contain a fragment of the eIF2
 
a
 
cDNA from the 3
 
9
 
 end of the full sequence (728–941 bp).
Antisense gene fragments from cDNA libraries in retrovi-
ral vectors have been used previously to identify physio-
logically relevant genes (Gudkov and Roninson, 1997). If
the downregulation of eIF2
 
a
 
 in the resistant clones is re-
sponsible for the resistance of the cells to glutamate, then
the expression of full-length eIF2
 
a
 
 should restore the sen-
sitivity to glutamate. Transfection of full-length eIF2
 
a
 
 hu-
man cDNA into both clones 8 and 15 restored glutamate
sensitivity to both of the clones, whereas the empty vector
had no effect (Fig. 2, B and C). The restoration of
glutamate sensitivity is not, however, up to the level of
wild-type cells at the highest glutamate concentrations,
probably because it was only possible to elevate eIF2
 
a
 
 to
80–90% of its original level (Fig. 1, B and C). Wild-type
HT22 cells remained sensitive to glutamate after being
transfected with the full-length eIF2
 
a
 
 cDNA (Fig. 2 A).
This demonstrates that modulation of eIF2
 
a
 
 expression
has significant effects on glutamate toxicity in HT22 cells.
 
eIF2
 
a
 
 Phosphorylation Also Mediates
Glutamate Resistance
To confirm that the loss of eIF2a activity is linked to
glutamate resistance, a second method was employed
which utilizes a dominant negative approach to regulate
eIF2a function. The phosphorylated form of eIF2a se-
questers the guanine nucleotide exchange factor, eIF2b,
resulting in a decrease in protein translation (Ernst et al.,
1987). The S51D mutant of eIF2a mimics constitutive
phosphorylation when serine 51 in eIF2a is replaced with
an aspartic acid (Kaufman et al., 1989). The S51A mutant
cannot be phosphorylated when serine 51 in eIF2a is re-
placed with alanine (Pathak et al., 1988). Thus, the S51D
mutant inhibits protein synthesis while the S51A mutant
prevents the shutdown of protein translation by the phos-
phorylation of eIF2a. To assay the effect of eIF2a phos-
phorylation on glutamate sensitivity, wild-type HT22 cells
were infected with virus that contained either the S51D or
Figure 2. Glutamate-resistant clones 8 and 15 ac-
quire glutamate sensitivity after transfection with
full-length eIF2a. Wild-type HT22 cells and
glutamate-resistant clones 8 and 15 were stably trans-
fected with an expression construct of eIF2a. (A)
The wild-type HT22 cells were unaffected by trans-
fection of eIF2a. (B and C) Resistant clones 8 and 15
when transfected with the eIF2a construct became
glutamate sensitive as detected by the MTT assay af-
ter 24 h of exposure to 2, 5, and 10 mM glutamate.
Samples were measured in triplicate (n 5 3).
Figure 3. HT22 cells become glutamate resistant when the eIF2a
S51D mutant is stably expressed. HT22 cells were infected with
virus containing either the pCLBABEpuro empty vector (r), the
S51A mutant of eIF2a (-s), or the eIF2a S51D mutant (m). Cell
viability was measured by the MTT assay. Samples were pre-
pared in triplicate (n 5 4).Tan et al. Oxidative Stress and eIF2a 1001
S51A mutant or an empty vector, and the cells were tested
for glutamate resistance. HT22 cells infected with virus
containing the mutant S51D become more resistant to
glutamate (Fig. 3). The S51A mutant of eIF2a did not
have any effect on the response of the cells to glutamate
relative to empty vector (Fig. 3). These data show that the
downregulation of eIF2a activity by protein phosphoryla-
tion can lead to glutamate resistance and that eIF2a phos-
phorylation may play an important role in cell death or
survival after glutamate exposure. However, we could not
directly assay eIF2a phosphorylation after glutamate ex-
posure because none of the available antibodies immuno-
precipitate or distinguish phosphorylated from unphos-
phorylated eIF2a in HT22 cells.
Changes in eIF2a Expression Do Not Affect 
Translation Rates but Do Slow Growth
To determine if eIF2a downregulation in the glutamate-resis-
tant clones causes a decrease in protein synthesis, protein
translation rates were measured in clones 8 and 15 as well as
in cells expressing mutants S51A and S51D. By inhibiting
translation with cycloheximide, HT22 cells are able to survive
in the presence of glutamate for short periods of time (Tan et
al., 1998a,b). Therefore, it was important to determine if the
inhibition of translation is the sole mechanism by which
clones 8 and 15 and the S51D mutant-expressing cell line be-
come resistant to oxidative stress. To measure the rate of
translation, cells were labeled with [3H]leucine for 30 min and
the total counts per minute of incorporated leucine per milli-
gram of protein calculated. The rate of translation in clone 15
is the same as in wild-type HT22 cells, but it is reduced about
twofold in clone 8 (Fig. 4 A). The rate of protein translation is
unchanged in HT22 cells after infection with retrovirus con-
taining the eIF2a mutants (S51A and S51D) or empty vector
(Fig. 4 B). Similarly, exposure of HT22 cells to glutamate
during a 10-h time course does not lead to any significant
changes in overall protein translation (data not shown).
These data indicate that the inhibition of overall protein syn-
thesis is not the mechanism underlying protection by eIF2a.
However, the translation rates do not reflect the growth rates
for each clone, as the growth rate of the wild-type HT22 cell
line is more than twofold faster than either clone 8 or 15 (Fig.
4 C). HT22 cells infected with the eIF2a mutant S51D also
have a slower growth rate than wild-type HT22 cells (Fig. 4
D) even though the protein translation rate of this mutant is
the same as that in the wild-type cells (Fig. 4 B). In contrast,
the S51A mutant has no significant effect on the translation
rate (Fig. 4 B) or the growth rate (Fig. 4 D). These data show
that changes in eIF2a expression or activation by phosphory-
lation may lead to alterations in cell growth but not necessar-
ily translation rates. However, it is possible that although the
bulk of protein synthesis is not altered, the synthesis of spe-
cific proteins required for cell proliferation and cell death is
regulated by altered eIF2a expression or phosphorylation.
Figure 4. Effect of eIF2a expression on the rate of protein trans-
lation. Protein synthesis was measured by [3H]leucine incorpora-
tion for 30 min and normalized to total protein. (A) Wild-type
HT22 cells (HT22); cells exposed to 5 mM glutamate for 4 h
(HT22  1  Glu); cycloheximide (HT22 1 Cx); and clones 8 and 15.
(B) Wild-type HT22 cells and cells infected with either empty
vector or the eIF2a phosphorylation mutants S51A or S51D. All
assays were performed in triplicate (n 5 2). (C) The growth rate
is decreased when eIF2a is downregulated or phosphorylated in
HT22 cells. Growth rates were measured by counting cells at 0,
24, 48, and 72 h after plating. Wild-type HT22 cells (j); resistant
clone 15 (s); and resistant clone 8 (r). (D) HT22 cells (j); cells
infected with empty vector (r); eIF2a mutant S51A (s); and
mutant S51D (s). Cell counts at all time points were done in
triplicate, and the data are presented as the average 6 SEM.
Figure 5. GSH levels in resistant cells. GSH levels were measured
in control, untreated cells, and cells exposed to 5 or 2 mM
glutamate for 10 h. (A) 5 mM glutamate. Clones 8 (white bars)
and 15 (hatched bars) have higher basal GSH levels than wild-
type HT22 and only deplete to 72 6 4 and 56 6 1% of their basal
GSH levels, respectively, with glutamate exposure. (B) 2 mM
glutamate. Wild-type HT22 cells (black bars), empty vector in-
fected cells (white bars), and S51A mutant infected cells (hatched
bars) show GSH levels that are depleted to 20–30% of basal lev-
els. In the S51D mutant-expressing cells (narrow hatched bars),
GSH depleted to only z50% of the basal level. 100% GSH is de-
fined as the GSH level assayed in the untreated control cells. The
numbers above the glutamate exposed bars indicate the percent-
age of GSH relative to the basal level in the same cell line (n 5 3).The Journal of Cell Biology, Volume 152, 2001 1002
eIF2a Expression Alters Glutathione, ROS, and Ca21 
Responses to Glutamate
To understand the role of eIF2a in oxidative glutamate
toxicity, several parameters of the glutamate response
were measured in the resistant clones and the S51A and
S51D mutant-expressing cell lines and compared with the
wild-type HT22 cells. HT22 cells undergo a rapid deple-
tion of GSH upon exposure to glutamate (Tan et al.,
1998b). After 8 h of exposure to glutamate, GSH levels
drop below 20% of their normal levels. Comparison of
wild-type HT22 cells to glutamate-resistant clones 8 and
15 after 10 h of exposure to 5 mM glutamate revealed that
the GSH levels in the resistant cells do not go below 50%
of the GSH levels in untreated resistant clones. Further-
more, before glutamate exposure, both cell lines have
higher GSH levels than untreated wild-type HT22 cells
(Fig. 5 A). The maximal difference in survival between the
S51D mutant-expressing cell line and the control HT22
cells is detected at 2 mM glutamate (Fig. 3). When GSH
levels in wild-type cells infected with the S51A or S51D
mutants or the empty vector are measured after 10 h of ex-
posure to 2 mM glutamate, the S51D mutant cell line
shows a decrease to z50% of the original level compared
with the 70% decrease in the wild-type and empty vector–
Figure 6. ROS and Ca21 levels after exposure to glutamate.
ROS levels were measured by flow cytometry using the fluo-
rescent dye DCF. (A) ROS levels increase 72-fold (gray line)
in wild-type HT22 cells exposed to 5 mM glutamate for 10 h.
However, ROS levels do not increase in resistant clones 8
and 15 after 10-h exposure to glutamate. (B) ROS levels af-
ter exposure to glutamate are increased (gray line) in wild-
type HT22 cells and in HT22 cells infected with empty vector
or the S51A mutant of eIF2a. ROS levels do not increase in
HT22 cells expressing the eIF2a mutant S51D when exposed
to 2 mM glutamate for 10 h. 10,000 live cells were assayed,
and the experiment was repeated two times with similar re-
sults. (C) Cytosolic Ca21 levels were measured using flow cy-
tometry and the ratiometric dye Indo-1. HT22 cells exposed
to 5 mM glutamate for 10 h have a large increase in cytosolic
Ca21 compared with untreated cells. After glutamate expo-
sure, resistant clones 8 and 15 maintain cytosolic Ca21 levels
similar to the wild-type untreated control. (D) HT22 cells ex-
posed to 2 mM glutamate for 10 h have a large increase in cy-
tosolic Ca21. HT22 cells infected with the empty vector or
the S51A mutant of eIF2 also show similar increases in Ca21.
The S51D mutant of eIF2a prevents the glutamate-induced
increase in Ca21 when stably expressed in HT22 cells. All
samples were prepared in duplicate. 10,000 live cells were as-
sayed in each experiment, and the study was repeated twice
with similar results.Tan et al. Oxidative Stress and eIF2a 1003
infected cells. On the other hand, the S51A mutant cell
line shows a decrease in GSH to z20% of control levels
(Fig. 5 B). This pattern of GSH depletion is consistent
with the survival data which demonstrate that although
the S51D-expressing HT22 cells are still healthy and divid-
ing after 24 h of glutamate exposure, the other cell lines
are dead (Fig. 3). HT22 cells exposed to glutamate for 10 h
show a very large increase in ROS which follows the drop
in GSH (Tan et al., 1998b). The fluorescent dye DCF was
used to determine the levels of ROS production by flow
cytometry in the resistant and mutant cell lines after expo-
sure to toxic levels of glutamate. The level of ROS in wild-
type HT22 cells after exposure to 5 mM glutamate for 10 h
is increased .70-fold (Fig. 6 A). In contrast, the glu-
tamate-resistant cell lines 8 and 15 do not show an in-
crease in ROS above normal levels, and the cells survive
and continue to divide (Fig. 6 A). When HT22 cells are ex-
posed to 2 mM glutamate for 10 h, the cells die and there is
an increase in ROS, although the DCF intensity is more
diffuse than with 5 mM glutamate (Fig. 6 B). The same
pattern of increased DCF is seen in cells expressing empty
vector and the mutant S51A. However, HT22 cells ex-
pressing the mutant S51D have low levels of ROS and
were able to survive glutamate treatment (Fig. 6 B). Fi-
nally, Ca21 influx was measured in wild-type, resistant, and
phosphorylation mutant-expressing cells. Ca21 levels were
determined by FACS® analysis using the ratiometric dye
Indo-1 (Tan et al., 1998b). After 10 h of exposure to 5 mM
glutamate, HT22 cells have much higher levels of Ca21
than untreated controls, whereas resistant cell lines 8 and
15 maintained intracellular Ca21 levels similar to those of
the wild-type HT22 cells (Fig. 6 C). The same experiment
was performed on the phosphorylation mutant-expressing
cell lines exposed to 2 mM glutamate. Ca21 levels increase
significantly in the wild-type HT22 cells as well as the
empty vector and S51A-expressing HT22 cells. The intra-
cellular Ca21 level in the S51D-expressing cells remained
similar to the HT22 cells that were not exposed to
glutamate (Fig. 6 D). These data show that both the down-
regulation of eIF2a in clones 8 and 15 and the expression
of the dominant negative phosphorylation mutant S51D
all prevent the decrease in GSH and the increases in ROS
and Ca21 normally associated with oxidative stress–induced
cell death.
The Inactivation of eIF2a Upregulates gGCS 
Expression by a Translational Mechanism
Resistant clones 8 and 15 have decreased eIF2a activity
and increased basal levels of GSH. Furthermore, the resis-
tant clones and the cells expressing the phosphorylation
mutant, S51D, maintain GSH levels 50% of their basal
levels after glutamate exposure. To determine if there is a
Figure 7. gGCS protein expression is regu-
lated at the level of translation. (A) gGCS,
actin protein, and mRNA expression was
measured in wild-type HT22 cells (lane 1),
cells infected with the empty vector
(pCLBABE) (lane 2), and the resistant
clones 8 (lane 3) and 15 (lane 4) by Western
and Northern blot analysis, respectively. (B)
The Western blot from A was analyzed using
the program NIH Image to determine the
densities of each band. The densities were
measured in four experiments, averaged, and
normalized first to actin and then to the level
of  gGCS in pCLBABE, set as 1.0. Actin
served as a loading control and showed that
there was an equal amount of protein in each
lane. Northern blots were quantitated on a
PhosphorImager. The ratio of the catalytic
subunit of gGCS to actin is presented nor-
malized to gGCS in pCLBABE as 1.0. The
results were confirmed by reverse transcrip-
tion PCR analysis (data not shown). (C) Pro-
teolytic breakdown of gGCS and P27 in wild-
type and resistant cells. HT22 cells and resistant
clone 15 were treated with 100 mg/ml cyclo-
heximide and the amount of gGCS and P27
was quantitated by Western blot at 2-h inter-
vals. The values are normalized to 0 time and
are the mean 6 SEM of triplicate experi-
ments. Inset, Western blots of gGCS, wild-
type cells (a); gGCS, clone 15 (b); P27, Cl 15
(c). Lanes 1, 2, 3, 4, and 5 are 0, 2, 4, 6, and 8 h after cycloheximide. x, gGCS, wild-type; d, gGCS Cl 15; s, P27. (D) Resistant clones 8
and 15 were infected with wild-type eIF2a, the wild-type HT22 clone was infected with S51A or S51D, and the levels of gGCS and actin
were determined by Western blotting. The amounts of gGCS and actin were quantitated and the amount of gGCS was normalized to
the actin loading control. In each set of cells, the transfected cells were then normalized to gGCS in their parental line pCLBABE, resis-
tant clone 8 or 15, which was set at 100%. The data are presented as the mean 6 SEM, n 5 4. *Significantly different from parental cells
(P , 0.01); **significantly different from parental cells (P , 0.05).The Journal of Cell Biology, Volume 152, 2001 1004
causal relationship between eIF2a protein levels and GSH
production, the expression of the rate-limiting enzyme for
GSH synthesis, gGCS, was examined in the wild-type cells
and the resistant clones. Protein expression and mRNA
levels of the catalytic subunit of gGCS were measured by
Western and Northern blotting, respectively. Western
blotting shows that the level of the catalytic subunit of
gGCS is threefold higher in the resistant clones than in the
wild-type HT22 cells (Fig. 7, A and B). In contrast, when
both gGCS and actin mRNA were quantitated and their
ratio normalized to cells expressing the empty pCLBABE
retroviral vector, the amount of gGCS mRNA remained
relatively constant (Fig. 7, A and B). To rule out the possi-
bility that eIF2a activity changes the rate of gGCS break-
down, resistant clone 15 and wild-type cells were treated
with cycloheximide and the rate of protein loss followed
by Western blotting. This method gives values of protein
turnover identical to pulse–chase experiments (Soucek et
al., 1998). The rapidly turned over cell cycle protein, P27,
served as a positive control (Soucek et al., 1998). Fig. 7 C
shows that in contrast to P27, gGCS was degraded more
slowly but at the same rate in resistant and wild-type cells.
These results indicate that a decrease in eIF2a wild-type
protein levels leads to an increase in production of the cat-
alytic subunit of gGCS by a translational mechanism, re-
sulting in significantly higher levels of GSH.
If eIF2a directly regulates gGCS expression, then its ex-
pression should be upregulated in wild-type cells made re-
sistant by the S51D phosphorylation mutant and downreg-
ulated in the resistant cells which were transfected with
wild-type eIF2a to render them more sensitive to oxida-
tive stress. Fig. 7 D shows that the levels of gGCS in-
creased z60% in cells transfected with S51D relative to
wild-type cells. In contrast, the expression of gGCS de-
creased between 20 and 40% in the resistant clones 8 and
15 which already have a high level of gGCS protein when
these clones were transfected with normal aIF2a (Fig. 7
B). These data, along with those presented above, strongly
suggest that eIF2a expression and activity can directly
modulate  gGCS protein levels. It is also likely that the ex-
pression of additional proteins involved in the resistance
to oxidative stress is regulated by eIF2a.
Discussion
The above data show that eIF2a plays a central role in pro-
grammed nerve cell death initiated by oxidative stress. Al-
terations in either the level of eIF2a or its phosphorylation
protect cells from glutamate-induced oxidative stress as well
as other prooxidant agents. We will first discuss the evi-
dence for the involvement of eIF2a in glutamate-induced
cell death, followed by possible mechanisms that eIF2a
could use to signal this type of cell death. The potential rele-
vance of eIF2a nerve cell death in PD will also be discussed.
eIF2a Is Specifically Involved in Oxidative
Glutamate Toxicity
HT22 glutamate-resistant clones 8 and 15 were derived from
a genetic screen after infection with a retrovirus-based cDNA
expression library and selection with a high concentration of
the prooxidant glutamate. Both clones contain an identical
fragment of the gene for eIF2a from the retroviral library.
The following evidence shows that eIF2a activity is required
for cells to die via oxidative glutamate toxicity and other
forms of oxidative stress: (a) eIF2a fragments rescued from
the glutamate-resistant cells make wild-type cells resistant to
glutamate upon reinfection; (b) Western blotting demon-
strates that the eIF2a protein levels in the resistant clones are
lower than in wild-type HT22 cells; and (c) eIF2a downregu-
lation alone causes resistance to glutamate since clones 8 and
15, when transfected with full-length human eIF2a, become
glutamate sensitive. Since eIF2a regulates the rate of protein
translation and cell death requires protein synthesis, it is pos-
sible that the inhibition of cell death simply reflects a de-
crease in the rate of protein synthesis in the resistant cells.
However, the decrease of eIF2a in the resistant cells did not
necessarily lead to a slower rate of protein synthesis. Al-
though clones 8 and 15 are equally resistant to glutamate,
only clone 8 has a rate of protein synthesis which is lower
than that in the wild-type cells. In addition, cells infected with
the eIF2a phosphorylation mutant S51D, which also induces
glutamate resistance, synthesize protein at a rate that is equal
to that of the wild-type cells. These results indicate that a de-
crease in the rate of translation per se does not lead to
glutamate resistance. Further evidence that eIF2a phosphor-
ylation plays a key role in determining the fate of the
glutamate-exposed HT22 cells is evident when the S51D mu-
tant of eIF2a is expressed in the HT22 cells, resulting in
glutamate resistance. The S51D mutant mimics a constitu-
tively phosphorylated form of eIF2a that cannot be dephos-
phorylated, such that it is able to sequester the guanine nucle-
otide exchange factor, eIF2B, and inhibit the initiation of
protein synthesis (Ernst et al., 1987; Kaufman et al., 1989).
Since the infection of HT22 cells with either eIF2a or the
phosphorylation mutants leads to overexpression of their re-
spective transcripts but does not alter the overall levels of
eIF2a protein (data not shown), the amount of eIF2a protein
that is synthesized must be highly regulated. In contrast to
our data, the S51D mutant causes apoptosis when transiently
transfected into another cell line (Srivastava et al., 1998), pre-
sumably because it shuts down protein synthesis. However, in
the HT22 cells expressing the S51D mutant, the cells main-
tain a normal protein synthesis rate, although the growth rate
is slower than in the wild-type cells (Fig. 4 D). One explana-
tion for how the HT22 cells infected with the S51D mutant
are able to maintain reasonable translation and growth rates
is that after infection with the S51D mutant, cells that greatly
overexpress the mutant die, whereas the cells that mildly
overexpress the mutant protein are able to survive at a
slightly slower growth rate. This is likely because the infected
cells become less resistant to glutamate with time. Therefore,
they probably express sufficient amounts of the S51D mutant
to survive glutamate exposure, but the cells that express the
lower amounts of the mutant insufficient for survival in
glutamate are eventually able to outgrow the other cells
when not in the presence of glutamate. 
eIF2a Downregulation and the Constitutively 
Phosphorylated Form of eIF2a Alter the Same 
Intermediates in the Cell Death Pathway
The observation that the two glutamate-resistant clones
selected by expression cloning and the overexpression
of the phosphorylation mutant, S51D, produce similar
changes in cell physiology during glutamate exposure fur-Tan et al. Oxidative Stress and eIF2a 1005
ther supports the critical role of eIF2a in the toxicity cas-
cade. These cell lines all exhibit higher GSH levels than
controls after glutamate exposure and lower levels of ROS
and intracellular Ca21. GSH levels in wild-type HT22 cells
decline to ,20% of controls after glutamate exposure,
whereas GSH levels in both the resistant clones and the
cells expressing the dominant negative S51D mutant drop
to ,50% of their basal levels. In contrast to control levels,
this level of GSH is sufficient to maintain cell viability (Sa-
gara and Schubert, 1998). The basal levels of GSH in the
resistant clones were also higher than in the wild-type
HT22 cells. It could be argued that the lower rate of trans-
lation and cell growth in the resistant cells frees up more
cysteine, allowing them to maintain a higher basal level of
GSH. However, clone 15 has a very high basal level of
GSH but a normal rate of protein synthesis, suggesting
that the resistant cells have higher GSH levels because
they actively produce greater amounts of this antioxidant.
The above results suggest that the downregulation or
phosphorylation of eIF2a during times of stress signals the
translation of specific proteins that increase cell survival.
Since decreases in either eIF2a activity or protein levels
both lead to an increase in GSH, we asked if the rate-limit-
ing enzyme in GSH production, gGCS, was increased in
the resistant cells compared with the wild-type HT22 cells.
Fig. 7 shows that although the amount of gGCS is in-
creased in the original resistant clones, the gGCS mRNA
level remains constant and there is no difference in the
rates of gGCS breakdown. In addition, gGCS is upregu-
lated by the phosphorylation mutant, S51D, and downreg-
ulated by the introduction of additional eIF2a into the
glutamate-resistant clones 8 and 15 (Fig. 7). These data
show that eIF2a regulates gGCS expression by a transla-
tional mechanism. Amino acid starvation in Saccharomy-
ces cerevisiae also causes eIF2a phosphorylation and leads
to the selective translation of one specific transcription
factor that signals the synthesis of amino acids so that the
yeast can survive starvation (Samuel, 1993). A mechanism
comparable to that employed by the yeast may be used in
HT22 cells when eIF2a activity is low, leading to an in-
creased production of gGCS to promote cell survival. In
addition, it was recently shown that another form of stress,
the unfolded protein response, causes the phosphorylation
of aIF2a and the increased translation of activating tran-
scription factor 4 (Harding et al., 2000).
eIF2a Plays a Unique Role in Programmed Cell Death
There have been several reports that positively link eIF2a
to apoptosis: eIF2a phosphorylation by double-stranded
RNA–activated protein kinase is the cause of cell death
in TNF-a–stimulated cells (Srivastava et al., 1998), and
eIF2a is cleaved by caspases after an increase in PKR ki-
nase activity induced by TNF-a or poly(I):poly(C) (Satoh
et al., 1999). However, HT22-resistant clones 8 and 15 are
not resistant to TNF-a, indicating that they utilize a sur-
vival mechanism that is unique to oxidative stress. Isch-
emia and reperfusion in the rat brain also lead to eIF2a
phosphorylation and cell death (DeGracia et al., 1997;
Burda et al., 1998). In these cases, it was argued that death
signals lead to eIF2a phosphorylation, protein synthesis
shutdown, and cell lysis. In contrast, our data show that
eIF2a phosphorylation protects cells from death. HT22
cells treated with thapsigargin, a substance shown to cause
eIF2a phosphorylation (Prostko et al., 1995), also leads to
cell survival after glutamate exposure (data not shown).
Finally, although it is generally assumed that any response
to central nervous system injury is part of the cell death
mechanism, it is equally likely that such a response is a
component of a survival pathway (Maher and Schubert,
2000). Therefore, the nature of the stimulus and the extent
of eIF2a phosphorylation determine whether eIF2a will
be used to prevent or promote cell death. The above ex-
periments link oxidative stress, GSH depletion, and the
regulation of gGCS directly to eIF2a and programmed
nerve cell death. Markers for both oxidative stress and the
depletion of intracellular GSH are found in areas of cen-
tral nervous system nerve cell death in PD (Sian et al.,
1994). However, in both PD and AD large numbers of
nerve cells do survive. It is therefore important to under-
stand the mechanisms which lead to resistance to oxidative
stress. In the brain, intracellular GSH is the single most
important antioxidant, and GSH-peroxidase breaks down
H2O2 and a variety of organic peroxides, thus protecting
cells from oxidative stress. The experiments presented
here show that changes in the expression level or phosphor-
ylation of a member of the protein translation complex,
eIF2a, can regulate the ability of a nerve cell to deal with
oxidative stress. This appears to be primarily done through
the regulation of GSH levels, as sustained GSH depletion
is the initial event which triggers downstream events such
as peroxide accumulation and ultimately cell death. Cells
with low amounts of eIF2a or phosphorylated eIF2a
maintain high levels of GSH when stressed and do not die.
These results point to a central role of eIF2a as a transla-
tional switch in the control of oxidative stress within the
nervous system. They also suggest a possible therapeutic
target for manipulating intracellular GSH levels.
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